BDPT — BIOADAPTIVES, INC.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1575142 ·
Last close
$0.01
Market Cap
$78.1K
52W High
$0.01
52W Low
$0.00
ADV30
15,600,177
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 5,514 | 4,113 | -198,218 | -111,086 | 135,949 | 73,606 | 2,272,091 |
| Dec 2025 | 10,427 | 7,583 | -248,117 | -823,346 | 225,901 | 158,445 | 2,355,957 |
| Sep 2025 | 4,632 | 3,851 | -265,689 | -379,502 | 124,360 | 59,273 | 1,589,570 |
| Jun 2025 | 3,219 | 1,063 | -279,219 | -157,914 | 272,515 | 210,582 | 1,407,813 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-502,958
Investing CF
$0
Financing CF
$549,115
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.09
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-10,832,290
Inventory
$42,968
Receivables
$0
ST Investments
—
EBIT TTM
$-1,322,858
Pretax Income TTM
$-1,471,848
Interest Exp TTM
$148,990
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$23,792
EBITDA
$-986,228
Free Cash Flow
$-129,716
Enterprise Value
$424,860
Total Cash
$73,606
Total Debt
$456,307
Shares Out
12,008,659
Trailing EPS
$-0.14
Book Value
$-0.18
ROE
—
ROA
-502.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 18,278 | -1,042,173 | -1,557,898 | 225,901 | 2,355,957 | — | -516,025 |
| Dec 2024 | 12,669 | -520,740 | -899,161 | 261,885 | 1,725,803 | — | -249,517 |
| Dec 2023 | 28,565 | -228,921 | -712,466 | 103,998 | 1,750,629 | — | -223,773 |
| Dec 2022 | 17,176 | -421,900 | -895,570 | 37,314 | 1,488,815 | — | -227,259 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RGBP | Regen BioPharma Inc | $76.8K | $0.00 | — |
| OCEA | Ocean Biomedical, Inc. | $92.9K | $0.00 | — |
| OWPC | One World Products, Inc. | $120.1K | $0.00 | — |
| PTPI | Petros Pharmaceuticals, Inc. | $131.4K | $0.00 | — |
| LIPO | LIPELLA PHARMACEUTICALS INC. | $152.5K | $0.03 | — |
News headlines (Yahoo Finance, 1h cache)
BioAdaptives Inc. Eliminates Major Market Overhang by Retiring the Debt of the Largest Convertible Commercial Investor
2026-07-30 12:30 · Yahoo
BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform
2026-07-29 17:15 · Yahoo
BioAdaptives Completes Commercial Supply Chain Ahead of MyndSystem and Xcellara Launches
2026-07-23 15:39 · Yahoo
BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches
2026-07-23 11:30 · Yahoo
BioAdaptives Outlines Xcellara Platform Strategy Ahead of XcellaraHeart Launch
2026-07-16 14:03 · Yahoo
BioAdaptives® Outlines Xcellara™ Platform Strategy: Integrating Stem Cell Supply and Direction for Targeted Wellness
2026-07-16 12:30 · Yahoo
BioAdaptives Announces XcellaraHeart Cardiovascular Wellness Formula Ahead of August Launch
2026-07-15 14:57 · Yahoo
BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara’s Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells
2026-07-15 12:30 · Yahoo
BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity
2026-06-25 18:48 · Yahoo
BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery
2026-05-20 20:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.